Indiana Code 12-15-35-40. Prospective DUR requisites
Current as of: 2023 | Check for updates
|
Other versions
Sec. 40. Prospective DUR must be based on the guidelines established by the board and must provide that prior to the prescription being filled or delivered a review will be conducted by the pharmacist at the point of sale to screen for potential drug therapy problems resulting from the following:
(2) Drug-drug interactions.
(1) Therapeutic duplication.
Terms Used In Indiana Code 12-15-35-40
- board: refers to the drug utilization review board created under this chapter. See Indiana Code 12-15-35-2
- DUR: means the program designed to measure and assess on a retrospective and a prospective basis the proper use of outpatient drugs in the Medicaid program. See Indiana Code 12-15-35-8
- pharmacist: means an individual who is licensed as a pharmacist in Indiana under IC 25-26. See Indiana Code 12-15-35-11
(3) Incorrect dosage and duration of treatment.
(4) Drug-allergy interactions.
(5) Clinical abuse and misuse.
As added by P.L.75-1992, SEC.19.